tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Holding ELTP?
Track your performance easily

Elite Pharmaceuticals (ELTP) Earnings Date & Reports

265 Followers

Earnings Data

Report Date
Feb 17, 2025
TBA Not Confirmed
Period Ending
2025 (Q3)
Consensus EPS Forecast
Last Year’s EPS
<$0.01
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 14, 2024
|
% Change Since: 6.19%
|
Next Earnings Date:Feb 17, 2025
Earnings Call Sentiment|Positive
The earnings call demonstrated strong revenue and profit growth, supported by a robust pipeline and strategic facility expansion, though some supply chain challenges and financial liabilities were noted.
Company Guidance
During the Elite Pharmaceuticals Q2 2025 earnings call, the company reported a robust financial performance with total revenues reaching $18.9 million for the quarter, marking a 33% increase from the previous year's same quarter, and $37.7 million for the first six months, reflecting a 63% year-over-year growth. Operating income also saw significant growth, with $3.5 million for the quarter and $7.3 million for the six months, representing an 81% and 108% increase respectively compared to last year. The company highlighted its strong cash flow, with a positive $4.6 million operating cash flow compared to a $2.9 million cash burn in the previous year, indicating a $7.5 million turnaround. Elite's working capital improved to $32.4 million, an increase of $5.5 million since March 31, 2024. The company's pipeline remains robust with several upcoming product launches, including hydrocodone with APAP, oxycodone with APAP, and methadone, and a significant CNS ANDA pending FDA approval. Elite’s balance sheet continues to strengthen with a $9.6 million cash reserve as of September 30, up by $2.5 million from March 31.
Record Revenue Growth
Total revenues for the quarter were $18.9 million, a $4.7 million or 33% increase from the previous year's quarter. Year-to-date revenues were $37.7 million, a $14.5 million or 63% increase compared to the previous year.
Significant Profit Increase
Operating income was $3.5 million for the quarter and $7.3 million for the six months, representing an 81% increase quarter-to-quarter and a 108% increase year-to-date compared to last year.
Strong Cash Flow Position
Operating cash flow for the six months ended September 2024 was a positive $4.6 million, a $7.5 million turnaround from the previous year's negative $2.9 million.
Pipeline Expansion
New product launches included methotrexate and Codeine APAP, with upcoming launches of hydrocodone and APAP, Oxy/APAP, and methadone. A pending ANDA approval for a central nervous system product is expected soon.
Facility Expansion
A new 35,000 square foot packaging and warehouse facility has been completed, tripling existing warehouse space and quadrupling controlled substance vault capacity.
---

Elite Pharmaceuticals (ELTP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ELTP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 17, 20252025 (Q3)
- / -
0.001
Nov 14, 20242025 (Q2)
- / -0.01
0.015-166.67% (-0.03)
Aug 14, 20242025 (Q1)
- / -
0.001
Jul 01, 20242024 (Q4)
- / <0.01
0.0010.00% (0.00)
Feb 14, 20242024 (Q3)
- / <0.01
0.003-66.67% (>-0.01)
Nov 14, 20232024 (Q2)
- / 0.01
0.002650.00% (+0.01)
Aug 14, 20232024 (Q1)
- / <0.01
0
Jun 29, 20232023 (Q4)
- / >-0.01
0.002-200.00% (>-0.01)
Feb 14, 20232023 (Q3)
- / <0.01
0.00250.00% (<+0.01)
Nov 15, 20222023 (Q2)
- / <0.01
0.001100.00% (<+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ELTP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 14, 2024$0.52$0.56+7.69%
Aug 14, 2024$0.20$0.19-5.00%
Jul 01, 2024$0.20$0.19-5.00%
Feb 14, 2024$0.20$0.18-10.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Elite Pharmaceuticals (ELTP) report earnings?
Elite Pharmaceuticals (ELTP) is schdueled to report earning on Feb 17, 2025, TBA Not Confirmed.
    What is Elite Pharmaceuticals (ELTP) earnings time?
    Elite Pharmaceuticals (ELTP) earnings time is at Feb 17, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ELTP EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis